.
.
researchers have developed a new artificial intelligence-based software which may identify and measure the severity of common causes of strokes and
.
.
.following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.